For the quarter ending 2025-09-30, STEK had -$17,034 decrease in cash & cash equivalents over the period. $24,971 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Net loss | -812,541 | -296,280 | -1,458,726 |
| Depreciation and amortization | 41,877 | 41,877 | 41,876 |
| Amortization of right of use asset | 0 | 0 | - |
| Operating lease liabilities | 0 | 0 | - |
| Stock compensation expense | 110,666 | 109,462 | 108,260 |
| Non-cash interest expense from issuance on debt (derivative) | 0 | 0 | 0 |
| Amortization of debt discount | 34,806 | -26,375 | -17,219 |
| Change in fair value of derivative liabilities | 0 | 0 | 0 |
| Gain (loss) on settlement of derivative liabilities | 0 | 0 | 0 |
| Stock issued for services | 488,061 | 0 | 211,809 |
| (gain) loss on extinguishment of debt | 0 | 0 | 0 |
| Accounts receivable | -20,958 | 87,138 | -9,442 |
| Inventory | -40,193 | 86,407 | -8,955 |
| Prepaid expenses and other current assets | 3,707 | 19,624 | -17,808 |
| Operating lease liabilities | - | 0 | 0 |
| Accounts payable and accrued expenses | 114,514 | 347,966 | 361,521 |
| Cancellation of shares returned by shareholders | - | 0 | 0 |
| Long term deposits | 0 | 0 | -452 |
| Amortization of right of use asset | - | - | 0 |
| Deferred revenues | -9,856 | 91,471 | 5,315 |
| Net cash used in operating activities | 24,971 | 74,952 | -710,507 |
| Purchase of property and equipment | 0 | 0 | 0 |
| Net cash used in investing activities | 0 | 0 | 0 |
| Proceeds from notes payable | -163,023 | 59,594 | 418,635 |
| Net proceeds from factoring arrangement | -107,927 | 471,113 | -287,806 |
| Repayment of note payable | 109,402 | -57,327 | -52,075 |
| Stock issued for cash | 0 | 0 | 0 |
| Proceeds from note payable - related parties | 0 | 0 | 0 |
| Net cash provided (used) by financing activities | -161,548 | 473,380 | 78,754 |
| Effects of currency translation on cash | 119,543 | -581,718 | 682,291 |
| Net increase (decrease) in cash | -17,034 | -33,386 | 50,538 |
| Cash and cash equivalents at beginning of period | 255,298 | - | - |
| Cash and cash equivalents at end of period | 255,416 | - | - |
Stemtech Corp (STEK)
Stemtech Corp (STEK)